Dominican Republic vs Puerto Rico: Tuberculosis treatment success rate by type
Dominican Republic
81
in 2023
Puerto Rico
81
in 2022
Dominican Republic rank
115th
Puerto Rico rank
115th
Tuberculosis treatment success rate by type over time
- Dominican Republic
- Puerto Rico
How they compare
Dominican Republic currently reports 81 against 81 in Puerto Rico, a difference of 0.
The two have swapped places 10 times across 28 shared years of data; in 1995 it was Puerto Rico ahead.
Dominican Republic ranks 115th and Puerto Rico ranks 115th of 194 countries.
Across the 4 decades both report, Dominican Republic averaged higher in 3 and Puerto Rico in 1.
Head to head by decade
| Decade | Dominican Republic | Puerto Rico | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 65.2 | 69.6 | 4.4 | Puerto Rico |
| 2000s | 73.2 | 71.6 | 1.6 | Dominican Republic |
| 2010s | 79.6 | 72.5 | 7.1 | Dominican Republic |
| 2020s | 82 | 79 | 3 | Dominican Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis treatment success rate by type, Dominican Republic or Puerto Rico?
- Dominican Republic, at 81 against 81 in Puerto Rico as of 2023.
- What is the difference in tuberculosis treatment success rate by type between Dominican Republic and Puerto Rico?
- 0, with Dominican Republic ahead.
- How many years of comparable data are there for Dominican Republic and Puerto Rico?
- 28 years are reported by both, from 1995 to 2022.
- How do Dominican Republic and Puerto Rico rank globally for tuberculosis treatment success rate by type?
- Dominican Republic ranks 115th and Puerto Rico ranks 115th of 194 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Tuberculosis treatment success rate by type. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The treatment success rate refers to the share of people diagnosed with tuberculosis (TB) who were either cured or completed their treatment according to the country’s treatment guidelines.